Phibro Animal Health | PAHC - 流动负债

金融业

USD 39.81

USD 1.5B

现金及等价物

USD 61.42M

USD 240.42M

USD 935.51M

USD 316.47M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 385.48M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.62B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 534.88M

贸易债权人

USD 127.31M

应收帐款人

USD 215.87M

	流动负债	更改		日
Align Technology	USD 1.91B		2.74M	2026-06
ANI Pharmaceuticals	USD 283.65M		44.14M	2026-06
Aurora Cannabis	CAD 66.93M		79M	2026-03
Bristol-Myers Squibb	USD 18.66B		499M	2026-06
Canopy Growth	CAD 158.44M		60.15M	2026-03
Corcept Therapeutics	USD 153.8M		4.62M	2026-06
Eli Lilly	USD 47.74B		11.11B	2026-06
Henry Schein	USD 3.49B		191M	2026-06
Idexx Laboratories	USD 1.29B		12.19M	2026-06
Knight Therapeutics	CAD 165.26M		12.58M	2025-12
Merck	USD 27.73B		786M	2026-06
Nektar Therapeutics	USD 57.71M		4.17M	2026-03
Pacira	USD 122.01M		13.22M	2026-06
Phibro Animal Health	USD 316.47M		34.6M	2026-06
Prestige Brands	USD 153.81M		32.88M	2026-06
Supernus Pharmaceuticals	USD 347.38M		26.55M	2026-06
Zoetis	USD 2.06B		8M	2026-06